← SynDRA
KETOCONAZOLE
SynDRA canonical compound SYN0005129 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | Sterol demethylase inhibitor |
|---|
| Indication | seborrheic dermatitis |
|---|
| Disease area | dermatology |
|---|
All known targets
- CYP19A1
- KCNA10
- CYP3A5
- AR
- CYP3A4
- CYP2C19
- CYP11B1
- CYP17A1
- Cyp27b1
- Cyp51a1
- Cyp7a1
- ERG11
Mechanisms of action (all sources)
- Sterol demethylase inhibitor
- CYP11A1 INHIBITOR
- CYP11B1 INHIBITOR
- CYP17A1 INHIBITOR
- CYP19A1 INHIBITOR
- CYP3A4 INHIBITOR
- CYP7A1 INHIBITOR
- KCNA10 MODULATOR
- Inhibitor
- ERG11 INHIBITOR
Drug classes
- Azole Antifungal
- 14-alpha Demethylase Inhibitors
- Anti-Infective Agents
- Antifungal Agents
- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P-450 Enzyme Inhibitors
- Enzyme Inhibitors
- Hormone Antagonists
- Metabolic Side Effects of Drugs and Substances
- Steroid Synthesis Inhibitors
- Cytochrome P450 3A4 Inhibitors
- P-Glycoprotein Inhibitors
ATC classes
- ANTIFUNGALS FOR TOPICAL USE
- ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
- ANTIADRENAL PREPARATIONS
- ANTIMYCOTICS FOR SYSTEMIC USE
Cross-references
Synonyms
- (+/-)-ketoconazole
- brizoral
- fungarest
- fungoral
- ketoderm
- ketoisdin
- ketozoral
- nizoral
- nizral
- panfungol
- ketoconazol
- R-41400
- Ketoconazol
- Ketoconazolum
- J02AB02
- NSC-317629
- R 41,400
- Daktarin gold
- Daktarin intensiv
- Dandrazol
- Dandrid
- Extina
- Ketoconazole hra
- Ketopine
- Ketozole
- Nizoral
- Nizoral a-d
- Nizoral anti-dandruff
- Nizorelle
- Xolegel
- KCZ
- KTZ
- K 1003
- R41400
- KS-1205
- KW-1414
- Perkhotal (TN)
- R41,400
Look up KETOCONAZOLE in the interactive SynDRA portal →